Lisata Therapeutics (NASDAQ: LSTA) — Perfil da empresa, notícias e dados financeiros
Lisata Therapeutics develops RNA-based therapies for cancer, enhancing patient care through innovative research and clinical trials.
Lisata Therapeutics
Lisata Therapeutics (NASDAQ:LSTA) is dedicated to developing innovative therapeutics for the treatment of cancer and other serious diseases. With a focus on crafting solutions that precisely target disease mechanisms, Lisata is at the forefront of creating next-generation treatments. Their projects span from early-stage research to advanced clinical trials, aiming to transform patient care and outcomes. Objectives include accelerating the development of their pipeline projects, expanding their research into new therapeutic areas, and establishing partnerships to enhance their reach and capabilities. Through relentless innovation and a commitment to excellence, Lisata Therapeutics strives to improve the quality of life for patients worldwide.
Resumo
Operações
Produtos e/ou serviços de Lisata Therapeutics
- Developing a unique delivery system for solid tumor treatment, leveraging targeted payload release.
- Advancing a novel oncology pipeline with proprietary technology aimed at improving cancer treatment outcomes.
- Creating personalized medicine solutions to enhance efficacy in cancer therapies.
- Innovating in drug delivery platforms to minimize side effects and optimize therapeutic impact.
- Collaborating on research projects with leading institutions to accelerate groundbreaking cancer treatments.
- Expanding into biotechnology services to support drug development and clinical trials for oncology.
equipe executiva do Lisata Therapeutics
- David J. MazzoCEO & Director
- James NiscoSVP of Finance and Treasury & Chief Accounting Officer
- Joshua Lehrer-GraiwerPresident & COO
Últimas notícias sobre a Lisata Therapeutics
Histórico de dividendos
Dividendos por ação pagos pela Lisata Therapeutics, por ano fiscal.
| Ano fiscal | Intermediário | Final | Especial | Total |
|---|---|---|---|---|
| FY2013 | — | — | — | $0.3100 |
| FY2011 | — | — | — | $0.2500 |
Principais indicadores financeiros
Resultados divulgados pela Lisata Therapeutics, em USD.
- Cap. de mercado
- 11 mi
- Receita (TTM)
- 100 mil
- P/L
- —
- LPA (diluído, TTM)
- -1.6
- Dividend yield
- —
- Margem de lucro
- 0.0%
| Fim do ano fiscal | Receita | Resultado operacional | Lucro líquido |
|---|---|---|---|
| 170 mil | -18,2 mi | -16,6 mi | |
| 1 mi | -22,4 mi | -20 mi | |
| 0 | -25,7 mi | -20,8 mi | |
| 121,4 mi | -57,6 mi | -54,2 mi |